{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:39:43Z","timestamp":1787801983888,"version":"build-2784847793"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"Importance<\/jats:title>The management of recurrent oropharyngeal cancer (rOPC) is complex. Curative options carry considerable risk of morbidity with overall poor prognosis. Little data exist on function and quality of life (QoL) outcomes for noncurative treatments. Even less is known about patient and carer experiences of function and QoL change over time when undergoing curative or noncurative treatment(s) for rOPC.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate the patient and caregiver experience of diagnosis, treatment, and living with recurrent oropharyngeal cancer and changes to function\/QoL.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>A longitudinal prospective and retrospective qualitative study was carried out at a specialist cancer center in the United Kingdom. Participants with a biopsy proven diagnosis of recurrent OPC and their caregivers were included. Participants were recruited between December 2022 and November 2023. Concurrent data analysis took took place between November 2023 and January 2024.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Curative salvage surgery or noncurative immunotherapy, chemotherapy, or clinical trials of investigational agents.<\/jats:p><\/jats:sec>Main Outcomes<\/jats:title>A framework-approach thematic analysis of semistructured, in-depth interviews.<\/jats:p><\/jats:sec>Results<\/jats:title>Twenty-two patients and 7 caregivers were recruited. Demographic data was collected via medical record review. The longitudinal sample included 8 male and 2 female individuals, and the median age was 62 (range, 47-77) years. The retrospective sample included 11 male individuals and 1 female individual, and the median age was 64 (range, 59-70) years. Eleven participants (50%) underwent curative treatment, and 11 (50%) noncurative treatment.Treatments included salvage surgery, immunotherapy, chemotherapy, or clinical trials. Patients and their caregivers contextualize their experience of recurrent disease in their past experience of primary disease diagnosis and treatment. Patients want to survive and when the options to choose between are cure or functional outcomes impacting health-related QoL, cure appears to be favored. However, when cure is not an option, patients appear to want to survive as long as possible. However, as the prognosis gets shorter there appears to be a shift in priorities where function\/QoL take precedence over survival.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This qualitative study found that treatment decision-making is extremely complex in the setting of rOPC. Quite often, decisions are made based on what is perceived by health care professionals to be functionally \u201ctoo morbid\u201d with salvage surgery, or \u201ckinder\u201d with life-prolonging noncurative treatments. However, patients are not always fully involved in these decisions and so shared decision-making does not always happen. To facilitate shared decision-making and informed consent, patients need to be given clear and accurate information on survival and function\/QoL outcomes for the various treatment modalities for rOPC.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoto.2024.3757","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:00:35Z","timestamp":1732204835000},"page":"97","source":"Crossref","is-referenced-by-count":7,"title":["Patient and Caregiver Experience of Diagnosis, Treatment, and Living With Recurrent Oropharyngeal Cancer"],"prefix":"10.1001","volume":"151","author":[{"given":"Grainne","family":"Brady","sequence":"first","affiliation":[{"name":"The Royal Marsden NHS Foundation Trust, London, United Kingdom"},{"name":"Department of Surgery & Cancer, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Roe","sequence":"additional","affiliation":[{"name":"The Royal Marsden NHS Foundation Trust, London, United Kingdom"},{"name":"Department of Surgery & Cancer, Imperial College London, London, United Kingdom"},{"name":"Imperial College Healthcare Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinidh","family":"Paleri","sequence":"additional","affiliation":[{"name":"The Royal Marsden NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"Lagergren","sequence":"additional","affiliation":[{"name":"Department of Surgery & Cancer, Imperial College London, London, United Kingdom"},{"name":"Department of Molecular medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Surgery & Cancer, Imperial College London, London, United Kingdom"},{"name":"Imperial College Healthcare Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"ooi240084r2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/0284186X.2020.1759822","article-title":"Rate of locoregional recurrence among patients with oropharyngeal squamous cell carcinoma with known HPV status: a systematic review.","volume":"59","author":"Asheer","year":"2020","journal-title":"Acta Oncol"},{"issue":"5","key":"ooi240084r3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/hed.26100","article-title":"Transoral robotic surgery for recurrent cancers of the upper aerodigestive tract-Systematic review and meta-analysis.","volume":"42","author":"Hardman","year":"2020","journal-title":"Head Neck"},{"issue":"S2","key":"ooi240084r4","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1017\/S002221511600061X","article-title":"Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.","volume":"130","author":"Mehanna","year":"2016","journal-title":"J Laryngol Otol"},{"issue":"s1","key":"ooi240084r5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.3233\/ACS-239001","article-title":"9th UK Swallow Research Group Conference: poster presentations abstracts.","volume":"26","author":"Brady","year":"2023","journal-title":"Adv Commun Swallowing"},{"issue":"3","key":"ooi240084r6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MOO.0000000000000620","article-title":"Changing paradigms in the treatment of residual\/recurrent head and neck cancer: implications for dysphagia management.","volume":"28","author":"Brady","year":"2020","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"12","key":"ooi240084r7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.oraloncology.2014.09.009","article-title":"Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?","volume":"50","author":"Roe","year":"2014","journal-title":"Oral Oncol"},{"key":"ooi240084r8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3389\/fonc.2019.00401","article-title":"Late effects of organ preservation treatment on swallowing and voice; presentation, assessment, and screening.","volume":"9","author":"Patterson","year":"2019","journal-title":"Front Oncol"},{"issue":"10","key":"ooi240084r9","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","article-title":"Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.","volume":"20","author":"Nichols","year":"2019","journal-title":"Lancet Oncol"},{"issue":"3","key":"ooi240084r10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/17549507.2013.861869","article-title":"The lived experience of dysphagia following non-surgical treatment for head and neck cancer.","volume":"16","author":"Nund","year":"2014","journal-title":"Int J Speech Lang Pathol"},{"issue":"4","key":"ooi240084r11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00455-014-9527-8","article-title":"Carers\u2019 experiences of dysphagia in people treated for head and neck cancer: a qualitative study.","volume":"29","author":"Nund","year":"2014","journal-title":"Dysphagia"},{"key":"ooi240084r12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/ACS-230001","article-title":"Patient experience, functional and quality of life outcomes in patients receiving surgical and non-surgical treatment for residual, recurrent, or new oropharyngeal cancer in a previously irradiated field: a systematic review.","volume":"26","author":"Brady","year":"2023","journal-title":"Adv Commun Swallowing"},{"issue":"1","key":"ooi240084r13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00520-020-05488-9","article-title":"A qualitative examination of patient priorities and preferences during treatment decision-making for recurrent head and neck cancer.","volume":"29","author":"Rhoten","year":"2021","journal-title":"Support Care Cancer"},{"key":"ooi240084r14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s41687-018-0060-7","article-title":"Patients\u2019 experience of recurrent\/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative study.","volume":"2","author":"Degboe","year":"2018","journal-title":"J Patient Rep Outcomes"},{"issue":"9","key":"ooi240084r15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations.","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"issue":"1","key":"ooi240084r18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research.","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"ooi240084r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41199-016-0017-6","article-title":"Informational and support needs of patients with head and neck cancer: current status and emerging issues.","volume":"1","author":"Fang","year":"2016","journal-title":"Cancers Head Neck"},{"issue":"8","key":"ooi240084r20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/cncr.31920","article-title":"Priorities, concerns, and regret among patients with head and neck cancer.","volume":"125","author":"Windon","year":"2019","journal-title":"Cancer"},{"issue":"8","key":"ooi240084r21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061654","article-title":"How do patients make decisions in the context of a multidisciplinary team: an ethnographic study of four head and neck cancer centres in the north of England.","volume":"12","author":"Hamilton","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"ooi240084r22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/17549507.2021.1977388","article-title":"Swallowing and communication outcomes following primary transoral robotic surgery for advanced or recurrent oropharyngeal cancer: case series.","volume":"24","author":"Charters","year":"2022","journal-title":"Int J Speech Lang Pathol"},{"issue":"12","key":"ooi240084r23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3109\/00016489.2015.1066935","article-title":"Salvage surgery for recurrent oropharyngeal cancer: post-operative oncologic and functional outcomes.","volume":"135","author":"Culi\u00e9","year":"2015","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"ooi240084r24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10147-012-0449-x","article-title":"Salvage surgery for recurrent oropharyngeal cancer after chemoradiotherapy.","volume":"18","author":"Kano","year":"2013","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"ooi240084r25","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hed.25557","article-title":"Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.","volume":"41","author":"Pipkorn","year":"2019","journal-title":"Head Neck"},{"key":"ooi240084r26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.oraloncology.2016.07.006","article-title":"Outcomes after surgical salvage for recurrent oropharyngeal squamous cell carcinoma.","volume":"60","author":"Sweeny","year":"2016","journal-title":"Oral Oncol"},{"issue":"8","key":"ooi240084r27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamaoto.2013.3866","article-title":"Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.","volume":"139","author":"White","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"10","key":"ooi240084r28","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hed.20438","article-title":"Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review.","volume":"28","author":"Frowen","year":"2006","journal-title":"Head Neck"},{"key":"ooi240084r29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fonc.2019.00783","article-title":"The role of response-shift in studies assessing quality of life outcomes among cancer patients: a systematic review.","volume":"9","author":"Ilie","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"ooi240084r30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1191\/0269216305pm1029oa","article-title":"Quality of life change and response shift in patients admitted to palliative care units: a pilot study.","volume":"19","author":"Echteld","year":"2005","journal-title":"Palliat Med"},{"key":"ooi240084r1","article-title":"Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition.","volume-title":"J Laryngol Otol","author":"Brady","year":"2024"},{"key":"ooi240084r17","author":"Ritchie","year":"1994"},{"key":"ooi240084r31","volume-title":"Division of Mental H, Prevention of Substance A. WHOQOL: measuring quality of life","author":"World Health Organization","year":"1997"},{"key":"ooi240084r16","unstructured":"Authority? HR. What is public involvement in research? Published 2024. Accessed 12th August 2024. https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/best-practice\/public-involvement\/"}],"container-title":["JAMA Otolaryngology\u2013Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2827118\/jamaotolaryngology_brady_2024_oi_240084_1738973204.77178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:18:12Z","timestamp":1739463492000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2827118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2024.3757","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,1]]}}}